Pharmabiz

Sanofi announces global employee shareholder plan to open on June 9

Sanofi announces global employee shareholder plan to open on June 9: Paris Friday, June 5, 2026, 18:00 Hrs [IST] Sanofi announced that its global employee shareholder plan, Action ...
Pharmabiz

Agilent, OpenAI & BCG collaborate to accelerate customer-focused, AI-driven scientific innovation

Agilent, OpenAI & BCG collaborate to accelerate customer-focused, AI-driven scientific innovation: Santa Clara, California Friday, June 5, 2026, 17:00 Hrs [IST] Agilent Technologi ...
Pharmabiz

Metropolis Healthcare recognised building a culture of quality and scientific excellence

Metropolis Healthcare recognised building a culture of quality and scientific excellence: Our Bureau, Bengaluru Friday, June 5, 2026, 16:20 Hrs [IST] Metropolis Healthcare has bee ...
Pharmabiz

Lupeng Pharma’s fourth-generation BTK inhibitor rocbrutinib approved in China for relapsed or refractory mantle cell lymphoma

Lupeng Pharma’s fourth-generation BTK inhibitor rocbrutinib approved in China for relapsed or refractory mantle cell lymphoma: Guangzhou, China Friday, June 5, 2026, 16:00 Hrs [ ...
Pharmabiz

Medical devices industry backs NMC's advisory on safe injection practices

Medical devices industry backs NMC's advisory on safe injection practices: Our Bureau, New Delhi Friday, June 5, 2026, 15:30 Hrs [IST] Medical devices industry and public health e ...
Pharmabiz

UK MHRA grants marketing approval to Madrigal Pharmaceuticals’ resmetirom to treat metabolic dysfunction-associated steatohepatitis in adults

UK MHRA grants marketing approval to Madrigal Pharmaceuticals’ resmetirom to treat metabolic dysfunction-associated steatohepatitis in adults: United Kingdom Friday, June 5, 202 ...
Pharmabiz

Glenmark Pharma launches lacosamide injection USP, 200 mg/20 mL (10 mg/mL), single-dose vials

Glenmark Pharma launches lacosamide injection USP, 200 mg/20 mL (10 mg/mL), single-dose vials: Our Bureau, Mumbai Friday, June 5, 2026, 14:30 Hrs [IST] Glenmark Pharmaceuticals In ...
Pharmabiz

Alembic Pharma receives US FDA final approval for haloperidol tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg & 20 mg

Alembic Pharma receives US FDA final approval for haloperidol tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg & 20 mg: Our Bureau, Mumbai Friday, June 5, 2026, 14:15 Hrs [IST] Alembic Pharm ...
Pharmabiz

US FDA grants orphan drug designation to Attralus Therapeutic’s zamubafusp alfa for the treatment of AL amyloidosis

US FDA grants orphan drug designation to Attralus Therapeutic’s zamubafusp alfa for the treatment of AL amyloidosis: Naples, Florida Friday, June 5, 2026, 14:00 Hrs [IST] Attral ...
Pharmabiz

Lupin receives US FDA approval for Ranluspec injection

Global pharma major Lupin Limited (Lupin) announced that the United States Food and Drug Administration (FDA) has approved its ranibizumab, Ranluspec (ranibizumab-hkdz), as an interchangeable ...
Pharmabiz

Lundbeck collaborates with Cradle to discover and optimize brain disorder treatments

Lundbeck collaborates with Cradle to discover and optimize brain disorder treatments: Valby, Denmark Friday, June 5, 2026, 13:00 Hrs [IST] Lundbeck A/S, a global biopharmaceutical ...
Pharmabiz

US FDA approves expanded use of Agilent’s PD-L1 IHC 22C3 pharmDx on Dako Omnis in ESCC, TNBC, and gastric or gastroesophageal junction adenocarcinoma

US FDA approves expanded use of Agilent’s PD-L1 IHC 22C3 pharmDx on Dako Omnis in ESCC, TNBC, and gastric or gastroesophageal junction adenocarcinoma: Santa Clara, California Fr ...